↓ Skip to main content

Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in European Child & Adolescent Psychiatry, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog
twitter
13 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
85 Mendeley
Title
Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial
Published in
European Child & Adolescent Psychiatry, April 2019
DOI 10.1007/s00787-019-01333-5
Pubmed ID
Authors

Seyedeh-Mahsa Mahdavinasab, Amene Saghazadeh, Nogol Motamed-Gorji, Salar Vaseghi, Mohammad-Reza Mohammadi, Rosa Alichani, Shahin Akhondzadeh

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 14%
Student > Master 11 13%
Student > Bachelor 9 11%
Student > Ph. D. Student 8 9%
Other 4 5%
Other 15 18%
Unknown 26 31%
Readers by discipline Count As %
Medicine and Dentistry 19 22%
Psychology 10 12%
Neuroscience 7 8%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 9 11%
Unknown 30 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2019.
All research outputs
#2,165,624
of 25,654,806 outputs
Outputs from European Child & Adolescent Psychiatry
#249
of 1,842 outputs
Outputs of similar age
#47,155
of 366,938 outputs
Outputs of similar age from European Child & Adolescent Psychiatry
#9
of 39 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.